Live Breaking News & Updates on Pulmonary arterial hypertension

Stay informed with the latest breaking news from Pulmonary arterial hypertension on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pulmonary arterial hypertension and stay connected to the pulse of your community

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, April 18, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's...

Atlanta , Georgia , United-states , Boston , Massachusetts , Miltonh-werner , Alex-lobo , Inhibikase-or-company , Nasdaq , Linkedin , Sternir-inc , Exchange-commission

Inhibikase Therapeutics (IKT) Issues Letter to Shareholders and Provides Update on Development Programs

Inhibikase Therapeutics (IKT) Issues Letter to Shareholders and Provides Update on Development Programs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Miltonh-werner , Inhibikase-therapeutics-inc , Inhibikase-or-company , Nasdaq , Institute-of-the-national-institutes-health , Drug-administration-for-ik , National-institute-of-neurological-disease , Inhibikase-therapeutics , Abelson-tyrosine-kinases , Fellow-shareholders , Drug-administration

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Georgia , Atlanta , Miltonh-werner , Alex-lobo , Linkedin , Youtube , Company-contact , Inhibikase-therapeutics-inc , Institute-of-the-national-institutes-health

North America Arterial Blood Gas Kits Market Expectations

North America Arterial Blood Gas Kits Market Expectations
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Report-pulmonary-arterial-hypertension , Global-markets-direct , Pulmonary-arterial-hypertension ,

Hand Eczema Market Report 2032: Epidemiology Data, Pipeline

Hand Eczema Market Report 2032: Epidemiology Data, Pipeline
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United-states , Spain , Germany , Pharmosa-biopharma , Astrazeneca , Pulmonary-arterial-hypertension , United-therapeutics , Respira-therapeutics , Gossamer-bio , Liquidia-technologies , Tenax-therapeutics , Aerovate-therapeutics

Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Milton-werner , Drug-administration , Inhibikase-therapeutics-inc , Nasdaq , Inhibikase-or-company , Division-of-cardiology , Office-of-cardiology , Inhibikase-therapeutics , Abelson-tyrosine-kinases , Pulmonary-arterial-hypertension , Chief-executive-officer , Arterial-hypertension

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial HypertensionBOSTON and ATLANTA, April 03, 2024 -- Inhibikase Therapeutics, Inc. , a...

Boston , Massachusetts , United-states , Atlanta , Georgia , Alex-lobo , Miltonh-werner , Milton-werner , Inhibikase-therapeutics-inc , Nasdaq , Drug-administration , Stern-investor-relations-inc

Inhibikase Announces Pre-IND Meeting For IkT-001Pro

Inhibikase Therapeutics, Inc. (IKT) announced it will meet with the Office of Cardiology, Hematology, Endocrinology and Nephrology in the Division of Cardiology and Nephrology at the FDA for a Pre-IND meeting to discuss IkT-001Pro as a treatment for Pulmonary Arterial Hypertension.

Milton-werner , More-such-health-news , Inhibikase-therapeutics-inc , Division-of-cardiology , Office-of-cardiology , Inhibikase-therapeutics , Pulmonary-arterial , Pulmonary-arterial-hypertension , Fda , Nhibikase- ,